Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesLiver transplantation cost in the model for end-stage liver disease era: Looking beyond the transplant admission
Liver Transplantation, 10/02/09
Salvalaggio PR et al. – High–MELD patients incur significantly higher costs prior to and at the time of LT. Following LT, the MELD score is not a significant predictor of cost or re–admission.
Related Articles
Simplifying hepatic venous outflow reconstruction in sequential living donor liver transplantation
Liver Transplantation, 10/30/09
Relevance Score: 72%
Diffuse liver diseases in neonatal and pediatric liver transplant candidates: a pictorial essay
Clinical Transplantation, 11/18/09
Relevance Score: 70%
Reduction in bile leaks following adult split liver transplant using a fibrin-collagen sponge: A pilot study
Digestive and Liver Diseases, 11/16/09
Relevance Score: 70%
Prognosis of adult patients transplanted with liver grafts < 35% of their standard liver volume
Liver Transplantation, 11/04/09
Relevance Score: 70%
Two-stage liver transplantation: an effective procedure in urgent conditions
Clinical Transplantation, 10/23/09
Relevance Score: 70%
Today in Hepatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) – lack of interference by iron deposition
British Journal of Haematology, 11/30/09
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial
The Lancet Oncology - Online First, 11/30/09
Optimizing the treatment of chronic viral hepatitis C
Expert Review of Gastroenterology & Hepatology, 11/30/09
Today in Transplant...keeping you current
Receive free subspecialty "5-minute updates" via email
Differential transcriptome patterns for acute cellular rejection in recipients with recurrent hepatitis C after liver transplantation
Liver Transplantation, 11/30/09
Clinical utility of an automated pupillometer for assessing and monitoring recipients of liver transplantation
Liver Transplantation, 11/30/09
Effect of ischemic preconditioning on the genomic response to reperfusion injury in deceased donor liver transplantation
Liver Transplantation, 11/30/09
Sponsor
Article Search
Sponsor